Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy
暂无分享,去创建一个
Edwin M. Stone | Elliott H. Sohn | Robert F. Mullins | Budd A. Tucker | S. Scott Whitmore | E. Stone | B. Tucker | E. Sohn | R. Mullins | A. Drack | S. S. Whitmore | K. Chirco | Kathleen R. Chirco | Arlene V. Drack | Edwin M. Stone
[1] A. Hofman,et al. Age-Related Macular Degeneration and Smoking , 2017 .
[2] E. Stone,et al. The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning. , 2014, The American journal of pathology.
[3] G. Abecasis,et al. No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38. , 2014, Ophthalmology.
[4] U. Schraermeyer,et al. Choriocapillaris breakdown precedes retinal degeneration in age-related macular degeneration , 2014, Neurobiology of Aging.
[5] Danielle B. Gutierrez,et al. Quantitative autofluorescence and cell density maps of the human retinal pigment epithelium. , 2014, Investigative ophthalmology & visual science.
[6] C. Curcio,et al. Cholesterol in the retina: The best is yet to come , 2014, Progress in Retinal and Eye Research.
[7] J. Guibourdenche,et al. Angiogenin Expression during Early Human Placental Development; Association with Blood Vessel Formation , 2014, BioMed research international.
[8] G. R. Jackson,et al. Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health. , 2014, Investigative ophthalmology & visual science.
[9] Johanna M Seddon,et al. Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration. , 2014, Human molecular genetics.
[10] K. Birke,et al. AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in mice , 2014, Gene Therapy.
[11] C. Eberhart,et al. Interleukin-17 Retinotoxicity Is Prevented by Gene Transfer of a Soluble Interleukin-17 Receptor Acting as a Cytokine Blocker: Implications for Age-Related Macular Degeneration , 2014, PloS one.
[12] R. Klein,et al. Measures of body shape and adiposity as related to incidence of age-related eye diseases: observations from the Beaver Dam Eye Study. , 2014, Investigative ophthalmology & visual science.
[13] J. Provis,et al. Synthesis and Propagation of Complement C3 by Microglia/Monocytes in the Aging Retina , 2014, PloS one.
[14] E. Stone,et al. Stem cells for investigation and treatment of inherited retinal disease , 2014, Human molecular genetics.
[15] M. Abràmoff,et al. Structural and biochemical analyses of choroidal thickness in human donor eyes. , 2014, Investigative ophthalmology & visual science.
[16] A. Bird,et al. Geographic atrophy: a histopathological assessment. , 2014, JAMA ophthalmology.
[17] Ivana K. Kim,et al. Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. , 2014, Investigative ophthalmology & visual science.
[18] Martin F. Kraus,et al. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. , 2014, Ophthalmology.
[19] Z. Ablonczy,et al. Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF‐A levels , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] Amitha Domalpally,et al. Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study. , 2014, Ophthalmology.
[21] M. van Lookeren Campagne,et al. A PHASE IA DOSE-ESCALATION STUDY OF THE ANTI-FACTOR D MONOCLONAL ANTIBODY FRAGMENT FCFD4514S IN PATIENTS WITH GEOGRAPHIC ATROPHY , 2014, Retina.
[22] Alauddin Bhuiyan,et al. Progress on retinal image analysis for age related macular degeneration , 2014, Progress in Retinal and Eye Research.
[23] Bernard Rosner,et al. Three New Genetic Loci (R1210C in CFH, Variants in COL8A1 and RAD51B) Are Independently Related to Progression to Advanced Macular Degeneration , 2014, PloS one.
[24] B. Tucker,et al. Loss of CD34 Expression in Aging Human Choriocapillaris Endothelial Cells , 2014, PloS one.
[25] V. Perry,et al. Fcγ receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration. , 2014, Investigative ophthalmology & visual science.
[26] D. Friedman,et al. Fear of falling in age-related macular degeneration , 2013, BMC Ophthalmology.
[27] Robert J Zawadzki,et al. Phase-variance optical coherence tomography: a technique for noninvasive angiography. , 2014, Ophthalmology.
[28] T. Keenan,et al. The Role of Complement in Age-Related Macular Degeneration: Heparan Sulphate, a ZIP Code for Complement Factor H? , 2013, Journal of Innate Immunity.
[29] T. Scheetz,et al. Altered gene expression in dry age-related macular degeneration suggests early loss of choroidal endothelial cells , 2013, Molecular vision.
[30] T. Takano,et al. Complement-mediated cellular injury. , 2013, Seminars in nephrology.
[31] Ivana K. Kim,et al. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. , 2013, Ophthalmology.
[32] S. Cashman,et al. Aurintricarboxylic acid inhibits complement activation, membrane attack complex, and choroidal neovascularization in a model of macular degeneration. , 2013, Investigative ophthalmology & visual science.
[33] V. Mahajan,et al. Combination therapy for neovascular age-related macular degeneration refractory to anti-vascular endothelial growth factor agents. , 2013, Ophthalmology.
[34] Sivakumar Gowrisankar,et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration , 2013, Nature Genetics.
[35] Margaret A. Pericak-Vance,et al. Identification of a Rare Coding Variant in Complement 3 Associated with Age-related Macular Degeneration , 2013, Nature Genetics.
[36] Yanhua Lin,et al. Comprehensive and sensitive quantification of long-chain and very long-chain polyunsaturated fatty acids in small samples of human and mouse retina. , 2013, Journal of chromatography. A.
[37] Cumulative association between age-related macular degeneration and less studied genetic variants in PLEKHA1/ARMS2/HTRA1: a meta and gene-cluster analysis , 2013, Molecular Biology Reports.
[38] Richard F Spaide,et al. Optical coherence tomography: imaging of the choroid and beyond. , 2013, Survey of ophthalmology.
[39] W. Gordon,et al. Mediator Lipidomics in Ophthalmology: Targets for Modulation in Inflammation, Neuroprotection and Nerve Regeneration , 2013, Current eye research.
[40] Min Zhang,et al. ARMS2 interference leads to decrease of proinflammatory mediators , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.
[41] Daniel M. Schwartz,et al. Optical imaging of the chorioretinal vasculature in the living human eye , 2013, Proceedings of the National Academy of Sciences.
[42] Sander R. Dubovy,et al. Variants at chromosome 10q26 locus and the expression of HTRA1 in the retina. , 2013, Experimental eye research.
[43] V. Mahajan,et al. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. , 2013, American journal of ophthalmology.
[44] Cynthia A. Toth,et al. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. , 2013, JAMA.
[45] B. Rovner,et al. Update on depression and age-related macular degeneration , 2013, Current opinion in ophthalmology.
[46] J. Handa,et al. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age‐related macular degeneration , 2013, The Journal of pathology.
[47] Usha Chakravarthy,et al. Clinical classification of age-related macular degeneration. , 2013, Ophthalmology.
[48] Gabriëlle H S Buitendijk,et al. Seven New Loci Associated with Age-Related Macular Degeneration , 2013, Nature Genetics.
[49] D. Uhrín,et al. Tissue-Specific Host Recognition by Complement Factor H Is Mediated by Differential Activities of Its Glycosaminoglycan-Binding Regions , 2013, The Journal of Immunology.
[50] C. Curcio,et al. SUBRETINAL DRUSENOID DEPOSITS IN NON-NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Morphology, Prevalence, Topography, and Biogenesis Model , 2013, Retina.
[51] E. Stone,et al. Chapter 42 – Macular Dystrophies , 2013 .
[52] T. Fujita,et al. The role of MASP-1/3 in complement activation. , 2013, Advances in experimental medicine and biology.
[53] Krishnamurthy V. Nemani,et al. The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition. , 2012, Developmental cell.
[54] J. Rousseau,et al. Activity limitation due to a fear of falling in older adults with eye disease. , 2012, Investigative ophthalmology & visual science.
[55] Christian Simader,et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. , 2012, Ophthalmology.
[56] M. Sonka,et al. Automated segmentation of the choroid from clinical SD-OCT. , 2012, Investigative ophthalmology & visual science.
[57] E. Aguilar,et al. Targeted deletion of Vegfa in adult mice induces vision loss. , 2012, The Journal of clinical investigation.
[58] D. Vavvas,et al. Enhanced Depth Imaging Optical Coherence Tomography in Age-related Macular Degeneration , 2012, Seminars in ophthalmology.
[59] Karun S. Arora,et al. Choroidal thickness change after water drinking is greater in angle closure than in open angle eyes. , 2012, Investigative ophthalmology & visual science.
[60] Adnan Tufail,et al. Evaluation of age-related macular degeneration with optical coherence tomography. , 2012, Survey of ophthalmology.
[61] Robert A Linsenmeier,et al. Oxygen consumption and distribution in the Long-Evans rat retina. , 2012, Experimental eye research.
[62] Yaou Duan,et al. Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids , 2012, Proceedings of the National Academy of Sciences.
[63] Masanori Hangai,et al. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. , 2012, Ophthalmology.
[64] M. Pennesi,et al. Animal models of age related macular degeneration. , 2012, Molecular aspects of medicine.
[65] B. Rohrer,et al. Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[66] M. Bennett,et al. Aging and Atherosclerosis: Mechanisms, Functional Consequences, and Potential Therapeutics for Cellular Senescence , 2012, Circulation research.
[67] G. Staurenghi,et al. The dark atrophy with indocyanine green angiography in Stargardt disease. , 2012, Investigative ophthalmology & visual science.
[68] Edwin M Stone,et al. Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with best vitelliform macular dystrophy. , 2012, Archives of ophthalmology.
[69] B. Kirchhof,et al. Immunohistochemical localization of complement regulatory proteins in the human retina. , 2012, Histology and histopathology.
[70] R. Mullins,et al. Effects of antioxidant components of AREDS vitamins and zinc ions on endothelial cell activation: implications for macular degeneration. , 2012, Investigative ophthalmology & visual science.
[71] Joan W. Miller,et al. Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[72] B. J. Klevering,et al. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. , 2012, Ophthalmology.
[73] P. Parham,et al. Review: Immunogenetics of human placentation. , 2012, Placenta.
[74] G. Ying,et al. Age Related Macular Degeneration - The Recent Advances in Basic Research and Clinical Care , 2012 .
[75] E. Sohn,et al. Bruch’s Membrane: The Critical Boundary in Macular Degeneration , 2012 .
[76] G. Ying,et al. THE ASSOCIATION BETWEEN DRUSEN EXTENT AND FOVEOLAR CHOROIDAL BLOOD FLOW IN AGE-RELATED MACULAR DEGENERATION , 2012, Retina.
[77] J. Haines,et al. THE ARMS2 A69S VARIANT AND BILATERAL ADVANCED AGE-RELATED MACULAR DEGENERATION , 2011, Retina.
[78] N. Hamajima,et al. C9-R95X polymorphism in patients with neovascular age-related macular degeneration. , 2012, Investigative ophthalmology & visual science.
[79] Sander R. Dubovy,et al. A novel ARMS2 splice variant is identified in human retina. , 2012, Experimental eye research.
[80] Aaron M. Newman,et al. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks , 2012, Genome Medicine.
[81] A. Zahr,et al. Expression and role of VEGF in the adult retinal pigment epithelium. , 2011, Investigative ophthalmology & visual science.
[82] Michael D Abràmoff,et al. Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[83] J. Tegnér,et al. Epigenetic alterations in autoimmune disease , 2011, Journal of Translational Medicine.
[84] T. Ideker,et al. High Temperature Requirement Factor A1 (HTRA1) Gene Regulates Angiogenesis through Transforming Growth Factor-β Family Member Growth Differentiation Factor 6* , 2011, The Journal of Biological Chemistry.
[85] A. Hopkinson,et al. Comparison of choroidal and retinal endothelial cells: characteristics and response to VEGF isoforms and anti-VEGF treatments. , 2011, Experimental eye research.
[86] W. Amoaku,et al. Comparative gene expression profiling of human umbilical vein endothelial cells and ocular vascular endothelial cells , 2011, British Journal of Ophthalmology.
[87] G. Superti-Furga,et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress , 2011, Nature.
[88] D. Bok,et al. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration , 2011, Proceedings of the National Academy of Sciences.
[89] E. Stone,et al. Elevated membrane attack complex in human choroid with high risk complement factor H genotypes. , 2011, Experimental eye research.
[90] C. Curcio,et al. Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy. , 2011, Experimental eye research.
[91] Christine A Curcio,et al. The oil spill in ageing Bruch membrane , 2011, British Journal of Ophthalmology.
[92] Wei Zhu,et al. A redox switch in C‐reactive protein modulates activation of endothelial cells , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[93] Amrita,et al. Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice , 2011, Proceedings of the National Academy of Sciences.
[94] E. Agrón,et al. Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration , 2011, Journal of Translational Medicine.
[95] N. Bressler,et al. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. , 2011, Archives of ophthalmology.
[96] I. Bhutto,et al. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration , 2011, British Journal of Ophthalmology.
[97] Glenn J Jaffe,et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. , 2011, The New England journal of medicine.
[98] D. Fearon,et al. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk , 2011, Proceedings of the National Academy of Sciences.
[99] G. Quellec,et al. Computational quantification of complex fundus phenotypes in age-related macular degeneration and Stargardt disease. , 2011, Investigative ophthalmology & visual science.
[100] P. Rosenfeld,et al. Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file. , 2011, American journal of ophthalmology.
[101] Alan W. Stitt,et al. Vascular stem cells and ischaemic retinopathies , 2011, Progress in Retinal and Eye Research.
[102] Se Woong Kang,et al. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. , 2011, Ophthalmology.
[103] Laura A. Hecker,et al. Copy number variation in the complement factor H-related genes and age-related macular degeneration , 2011, Molecular vision.
[104] J. Corbo,et al. Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency. , 2011, Human molecular genetics.
[105] Robert F Mullins,et al. Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[106] Nicolas Leveziel,et al. ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. , 2011, American journal of ophthalmology.
[107] N. Hamajima,et al. Elevated C-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration , 2010, Molecular vision.
[108] Yanhua Lin,et al. Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration , 2010, Journal of Lipid Research.
[109] N. Yoshimura,et al. Haplotype analysis of the ARMS2/HTRA1 region in Japanese patients with typical neovascular age-related macular degeneration or polypoidal choroidal vasculopathy , 2010, Japanese Journal of Ophthalmology.
[110] A. Reiner,et al. Projections from the hypothalamic paraventricular nucleus and the nucleus of the solitary tract to prechoroidal neurons in the superior salivatory nucleus: Pathways controlling rodent choroidal blood flow , 2010, Brain Research.
[111] S. Russell,et al. Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. , 2010, Investigative ophthalmology & visual science.
[112] Robyn H Guymer,et al. An intergenic region between the tagSNP rs3793917 and rs11200638 in the HTRA1 gene indicates association with age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.
[113] Richard F Spaide,et al. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. , 2010, Ophthalmology.
[114] Z. Bian,et al. Induction of interleukin-8 gene expression and protein secretion by C-reactive protein in ARPE-19 cells. , 2010, Experimental eye research.
[115] B. Rosner,et al. C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration. , 2010, Ophthalmology.
[116] D. Bernlohr,et al. Fatty acid flux in adipocytes: The in's and out's of fat cell lipid trafficking , 2010, Molecular and Cellular Endocrinology.
[117] Christine A. Curcio,et al. Abundant Lipid and Protein Components of Drusen , 2010, PloS one.
[118] D. S. Mcleod,et al. Development of the human choriocapillaris , 2010, Eye.
[119] E. Agrón,et al. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. , 2010, Ophthalmology.
[120] Don H. Anderson,et al. The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited , 2010, Progress in retinal and eye research.
[121] C. Curcio,et al. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration , 2010, Journal of Lipid Research.
[122] Josh Wallman,et al. The multifunctional choroid , 2010, Progress in Retinal and Eye Research.
[123] J. Hollyfield,et al. Quantitative Proteomics: Comparison of the Macular Bruch Membrane/Choroid Complex from Age-related Macular Degeneration and Normal Eyes , 2010, Molecular & Cellular Proteomics.
[124] C. Curcio,et al. Reticular pseudodrusen are subretinal drusenoid deposits. , 2010, Ophthalmology.
[125] C. Costagliola,et al. Enhanced depth imaging spectral-domain optical coherence tomography. , 2010, Retina.
[126] A. Flyvbjerg. Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily , 2010, Nature Reviews Endocrinology.
[127] S. A. Meyer,et al. RELATIONSHIP BETWEEN PHOTORECEPTOR OUTER SEGMENT LENGTH AND VISUAL ACUITY IN DIABETIC MACULAR EDEMA , 2009, Retina.
[128] R. Wallis,et al. Paths reunited: Initiation of the classical and lectin pathways of complement activation. , 2010, Immunobiology.
[129] E. Kremmer,et al. ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. , 2010, Investigative ophthalmology & visual science.
[130] M C Gillies,et al. Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration , 2009, British Journal of Ophthalmology.
[131] Magali Saint-Geniez,et al. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris , 2009, Proceedings of the National Academy of Sciences.
[132] Christine A. Curcio,et al. Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins , 2009, Progress in Retinal and Eye Research.
[133] Ami Miller,et al. Complement Factor H Binds at Two Independent Sites to C-reactive Protein in Acute Phase Concentrations*♦ , 2009, The Journal of Biological Chemistry.
[134] Takayuki Baba,et al. Relationship between RPE and choriocapillaris in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[135] E. Connolly,et al. The complement cascade as a therapeutic target in intracerebral hemorrhage , 2009, Experimental Neurology.
[136] P. Zipfel,et al. Complement regulators and inhibitory proteins , 2009, Nature Reviews Immunology.
[137] J. Izatt,et al. Spectral domain optical coherence tomography imaging of geographic atrophy margins. , 2009, Ophthalmology.
[138] Frederick L Ferris,et al. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. , 2009, Archives of ophthalmology.
[139] Michael G. Anderson,et al. The podosomal-adaptor protein SH3PXD2B is essential for normal postnatal development , 2009, Mammalian Genome.
[140] A. Murphy,et al. Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques , 2009, Circulation research.
[141] J. Filep. Platelets affect the structure and function of C-reactive protein. , 2009, Circulation research.
[142] M. Peakman,et al. Level of major histocompatibility complex class I expression on endothelium in non‐obese diabetic mice influences CD8 T cell adhesion and migration , 2009, Clinical and experimental immunology.
[143] J. Haines,et al. Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. , 2009, Investigative ophthalmology & visual science.
[144] R. Yamada,et al. ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. , 2009, American journal of ophthalmology.
[145] Richard F Spaide,et al. Age-related choroidal atrophy. , 2009, American journal of ophthalmology.
[146] T. Lehtimäki,et al. Complement factor H 402His variant confers an increased mortality risk in Finnish nonagenarians: The Vitality 90+ study , 2009, Experimental Gerontology.
[147] R. Mullins,et al. Macrophages in neovascular age-related macular degeneration: friends or foes? , 2009, Eye.
[148] J. Bena,et al. Assessing Susceptibility to Age-related Macular Degeneration with Proteomic and Genomic Biomarkers* , 2009, Molecular & Cellular Proteomics.
[149] C. Curcio,et al. Lipoprotein particles of intraocular origin in human Bruch membrane: an unusual lipid profile. , 2009, Investigative ophthalmology & visual science.
[150] C. Eklund. Proinflammatory cytokines in CRP baseline regulation. , 2009, Advances in clinical chemistry.
[151] M. Daly,et al. Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.
[152] M. Xiong,et al. Multifactor Effects and Evidence of Potential Interaction between Complement Factor H Y402H and LOC387715 A69S in Age-Related Macular Degeneration , 2008, PloS one.
[153] J. Ott,et al. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss , 2008, Journal of Medical Genetics.
[154] J. Nielsen,et al. Novel functions of the CD34 family , 2008, Journal of Cell Science.
[155] P. Mitchell,et al. The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples. , 2008, Ophthalmology.
[156] J. Ott,et al. Rhesus monkeys and humans share common susceptibility genes for age-related macular disease. , 2008, Human molecular genetics.
[157] Steffen Schmitz-Valckenberg,et al. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.
[158] Martin Oppermann,et al. Systemic Complement Activation in Age-Related Macular Degeneration , 2008, PloS one.
[159] S. Fisher,et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.
[160] Ivana K. Kim,et al. Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. , 2008, Ophthalmology.
[161] Sebastian Wolf,et al. Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. , 2008, Investigative ophthalmology & visual science.
[162] S. Vuk-Pavlović,et al. Immune cells in the human choroid , 2008, British Journal of Ophthalmology.
[163] Ivana K. Kim,et al. The NEI/NCBI dbGAP database: Genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration , 2008, BMC Medical Genetics.
[164] Thomas J. Lukas,et al. The Aged Retinal Pigment Epithelium/Choroid: A Potential Substratum for the Pathogenesis of Age-Related Macular Degeneration , 2008, PloS one.
[165] C. Curcio,et al. Morphometric analysis of lipoprotein-like particle accumulation in aging human macular Bruch's membrane. , 2008, Investigative ophthalmology & visual science.
[166] Thomas S Hwang,et al. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. , 2008, Ophthalmology.
[167] J. Tong,et al. Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.
[168] B. Nilsson,et al. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). , 2008, Molecular immunology.
[169] J. Matsubara,et al. Complement-associated deposits in the human retina. , 2008, Investigative ophthalmology & visual science.
[170] Joe G Hollyfield,et al. Oxidative damage–induced inflammation initiates age-related macular degeneration , 2008, Nature Medicine.
[171] A. Coleman,et al. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999. , 2008, Ophthalmology.
[172] John D. Lambris,et al. The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.
[173] Justine R. Smith,et al. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin. , 2007, Molecular vision.
[174] Gonçalo R. Abecasis,et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration , 2007, Proceedings of the National Academy of Sciences.
[175] Cynthia Owsley,et al. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. , 2007, Ophthalmology.
[176] Gisèle Soubrane,et al. Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. , 2007, Archives of ophthalmology.
[177] I. Deary,et al. Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.
[178] D. S. Mcleod,et al. The embryonic human choriocapillaris develops by hemo‐vasculogenesis , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.
[179] C. Curcio,et al. Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch. , 2007, Experimental eye research.
[180] S. Thiel,et al. New perspectives on mannan-binding lectin-mediated complement activation. , 2007, Immunobiology.
[181] B. van Ginneken,et al. Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color fundus photographs for diabetic retinopathy diagnosis. , 2007, Investigative ophthalmology & visual science.
[182] Gary C. Brown,et al. Age-related macular degeneration: the costs to society and the patient , 2007, Current opinion in ophthalmology.
[183] F. Ferris,et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. , 2007, Archives of ophthalmology.
[184] Don H. Anderson,et al. Y402H Polymorphism of Complement Factor H Affects Binding Affinity to C-Reactive Protein1 , 2007, The Journal of Immunology.
[185] R. Linsenmeier,et al. Hyperoxia improves oxygen consumption in the detached feline retina. , 2007, Investigative ophthalmology & visual science.
[186] M. Killingsworth,et al. Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.
[187] Ronald Klein,et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2007, Ophthalmology.
[188] A. Reiner,et al. Age-related decline in VIP-positive parasympathetic nerve fibers in the human submacular choroid. , 2007, Investigative ophthalmology & visual science.
[189] N. D. Wangsa-Wirawan,et al. Oxygen distribution and consumption in the macaque retina. , 2006, American journal of physiology. Heart and circulatory physiology.
[190] W. Green,et al. Human HtrA1 in the archived eyes with age-related macular degeneration. , 2007, Transactions of the American Ophthalmological Society.
[191] Edwin M Stone,et al. Complement factor H polymorphism p.Tyr402His and cuticular Drusen. , 2007, Archives of ophthalmology.
[192] John D Lambris,et al. Ancient origin of the complement system: emerging invertebrate models. , 2007, Advances in experimental medicine and biology.
[193] Chi Pui Pang,et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.
[194] K. Eng,et al. Ranibizumab in neovascular age-related macular degeneration , 2006, Clinical interventions in aging.
[195] M. Radeke,et al. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid , 2006, Proceedings of the National Academy of Sciences.
[196] N. Camp,et al. A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.
[197] I. Rodriguez,et al. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. , 2006, Molecular vision.
[198] Susan Schneider,et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[199] C. Curcio,et al. Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina. , 2006, Experimental eye research.
[200] N. Orr,et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration , 2006, Nature Genetics.
[201] John D Lambris,et al. First Identification of a Chemotactic Receptor in an Invertebrate Species: Structural and Functional Characterization of Ciona intestinalis C3a Receptor , 2006, The Journal of Immunology.
[202] J. Sears,et al. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration , 2006, Proceedings of the National Academy of Sciences.
[203] R. Ritch,et al. Ethnic variation in AMD‐associated complement factor H polymorphism p.Tyr402His , 2006, Human mutation.
[204] Johanna M Seddon,et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.
[205] M. Nonaka,et al. Genomic view of the evolution of the complement system , 2006, Immunogenetics.
[206] W. Neuhuber,et al. The autonomic facial nerve pathway in birds: a tracing study in chickens. , 2006, Investigative ophthalmology & visual science.
[207] Magali Saint-Geniez,et al. VEGF expression and receptor activation in the choroid during development and in the adult. , 2006, Investigative ophthalmology & visual science.
[208] J. Haines,et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. , 2006, American journal of human genetics.
[209] J. Provis,et al. Endothelial cell proliferation in the choriocapillaris during human retinal differentiation , 2006, British Journal of Ophthalmology.
[210] R. Mullins,et al. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. , 2006, Molecular vision.
[211] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[212] J. Thurman,et al. The Central Role of the Alternative Complement Pathway in Human Disease1 , 2006, The Journal of Immunology.
[213] C. Wanner,et al. C-reactive protein: a family of proteins to regulate cardiovascular function. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[214] John D Lambris,et al. Drusen complement components C3a and C5a promote choroidal neovascularization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[215] Peter K. Kaiser,et al. ANCHOR STUDY GROUP. RANIBIZUMAB VERSUS VERTEPORFIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2006 .
[216] Don H. Anderson,et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. , 2006, Annals of medicine.
[217] G. Malek,et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[218] D. S. Mcleod,et al. Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroid , 2005, Vision Research.
[219] Ronald Klein,et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. , 2005, Archives of ophthalmology.
[220] Matthew D. Davis,et al. The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration , 2015 .
[221] W. Hodos,et al. Anatomical and functional evidence for progressive age-related decline in parasympathetic control of choroidal blood flow in pigeons. , 2005, Experimental eye research.
[222] C. Owsley,et al. The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study , 2005, British Journal of Ophthalmology.
[223] R. Mullins,et al. Glycoconjugates of choroidal neovascular membranes in age-related macular degeneration. , 2005, Molecular vision.
[224] Philip J Rosenfeld,et al. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. , 2005, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[225] Jurg Ott,et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. , 2005, American journal of human genetics.
[226] C. Curcio,et al. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. , 2005, Investigative ophthalmology & visual science.
[227] B. Rosner,et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. , 2005, Archives of ophthalmology.
[228] C. Curcio,et al. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. , 2005, Experimental eye research.
[229] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[230] C. Osmond,et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. , 2005, Investigative ophthalmology & visual science.
[231] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[232] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[233] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[234] C. Curcio,et al. Retina expresses microsomal triglyceride transfer protein: Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.M400428-JLR200implications for age-related maculopathys⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional table. , 2005, Journal of Lipid Research.
[235] E. Lütjen-Drecoll,et al. Choroidal Ganglion Cells in Prenatal, Young, and Middle-Aged Human Donor Eyes , 2005, Current eye research.
[236] D. Weeks,et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. , 2005, American journal of human genetics.
[237] Lars G Fritsche,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. , 2005, Human molecular genetics.
[238] P. Penfold,et al. Senile macular degeneration: The involvement of immunocompetent cells , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[239] M. Tomi,et al. Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. , 2005, Biological & pharmaceutical bulletin.
[240] A. Bird,et al. Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. , 2004, Investigative ophthalmology & visual science.
[241] V. Sheffield,et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. , 2004, The New England journal of medicine.
[242] D. Boase. Treatment of age-related macular degeneration , 2004, Journal of the Royal Society of Medicine.
[243] A. Bird,et al. Cytoarchitecture of choroidal capillary endothelial cells. , 2004, Investigative ophthalmology & visual science.
[244] L. Smith,et al. The sea urchin complement homologue, SpC3, functions as an opsonin , 2004, Journal of Experimental Biology.
[245] J. Filep,et al. Conformational Rearrangement in C-Reactive Protein Is Required for Proinflammatory Actions on Human Endothelial Cells , 2004, Circulation.
[246] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[247] R. Klein,et al. Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.
[248] N. Rifai,et al. Association between C-reactive protein and age-related macular degeneration. , 2004, JAMA.
[249] E. Lütjen-Drecoll,et al. Immunohistochemical classification and functional morphology of human choroidal ganglion cells. , 2004, Investigative ophthalmology & visual science.
[250] J. Brunette,et al. Rod-cone differences in response to retinal ischemia in rabbit , 1986, Documenta Ophthalmologica.
[251] B. Rosner,et al. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. , 2003, Archives of ophthalmology.
[252] J. Forrester. Macrophages eyed in macular degeneration , 2003, Nature Medicine.
[253] M. Miyagi,et al. Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration* , 2003, Journal of Biological Chemistry.
[254] Joan W. Miller,et al. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.
[255] N. D. Wangsa-Wirawan,et al. Retinal Oxygen Fundamental and Clinical Aspects , 2003 .
[256] C. Curcio,et al. Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch's membrane. , 2003, Investigative ophthalmology & visual science.
[257] Masaru Miyagi,et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[258] L. D. Del Priore,et al. Age-related changes in human RPE cell density and apoptosis proportion in situ. , 2002, Investigative ophthalmology & visual science.
[259] D. S. Mcleod,et al. Immunohistochemical staining and morphometric analysis of the monkey choroidal vasculature. , 2002, Experimental eye research.
[260] R. Flower,et al. Clinical observations supporting a theoretical model of choriocapillaris blood flow in treatment of choroidal neovascularization associated with age-related macular degeneration. , 2002, American journal of ophthalmology.
[261] H. Grossniklaus,et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. , 2002, Molecular vision.
[262] G. Taubes. Does Inflammation Cut to the Heart of the Matter? , 2002, Science.
[263] Neil M Bressler,et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.
[264] L. V. Johnson,et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.
[265] A. Hutchinson,et al. Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy. , 2001, Ophthalmology.
[266] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[267] D. Weeks,et al. Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. , 2001, American journal of ophthalmology.
[268] W. Willett,et al. Dietary fat and risk for advanced age-related macular degeneration. , 2001, Archives of ophthalmology.
[269] C. Curcio. Photoreceptor topography in ageing and age-related maculopathy , 2001, Eye.
[270] G. Hageman,et al. Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.
[271] C. Wahlestedt,et al. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[272] D F Schorderet,et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. , 2001, Archives of ophthalmology.
[273] N Rifai,et al. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. , 2001, Clinical chemistry.
[274] M. Nonaka. Evolution of the complement system. , 2001, Current opinion in immunology.
[275] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[276] R. Klein,et al. Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. , 2001, Archives of ophthalmology.
[277] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[278] H. Rus,et al. The complement system in central nervous system diseases , 2001, Immunologic research.
[279] James T. Willerson,et al. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.
[280] R. Linsenmeier,et al. Metabolic dependence of photoreceptors on the choroid in the normal and detached retina. , 2000, Investigative ophthalmology & visual science.
[281] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[282] V. Sheffield,et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.
[283] L. V. Johnson,et al. A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.
[284] M. C. Leske,et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. , 2000, Archives of ophthalmology.
[285] S. Russell,et al. Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. , 2000, American journal of ophthalmology.
[286] A C Bird,et al. A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. , 1999, Archives of ophthalmology.
[287] M. Tymms. Sorsby's fundus dystrophy: what does TIMP3 tell us about general mechanisms underlying macular degeneration? , 1999, Clinical & experimental optometry.
[288] C. Mangione,et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. , 1999, American journal of ophthalmology.
[289] C. Curcio,et al. Basal linear deposit and large drusen are specific for early age-related maculopathy. , 1999, Archives of ophthalmology.
[290] M. Killingsworth,et al. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study , 1999, The British journal of ophthalmology.
[291] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[292] T. Matise,et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.
[293] G. Ripandelli,et al. Optical coherence tomography. , 1998, Seminars in ophthalmology.
[294] J. Lupski,et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. , 1997, Science.
[295] H. Grossniklaus,et al. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. , 1996, Investigative ophthalmology & visual science.
[296] W. Willett,et al. A prospective study of cigarette smoking and age-related macular degeneration in women. , 1996, JAMA.
[297] R J Glynn,et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. , 1996, JAMA.
[298] R. Klein,et al. Pattern of age-related maculopathy in the macular area. The Beaver Dam Eye Study. , 1996, Investigative ophthalmology & visual science.
[299] A. Hofman,et al. Age-related macular degeneration and smoking. The Rotterdam Study. , 1996 .
[300] Chandra L. Theesfeld,et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[301] J. Marshall,et al. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. , 1996, Experimental eye research.
[302] S. Owens,et al. Indocyanine green angiography. , 1996, The British journal of ophthalmology.
[303] V. Sheffield,et al. Linkage of autosomal dominant radial drusen (malattia leventinese) to chromosome 2p16-21. , 1996, Archives of ophthalmology.
[304] D. Lefer,et al. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. , 1995, The American journal of pathology.
[305] P T de Jong,et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .
[306] M. Killingsworth,et al. RETICULAR PSEUDODRUSEN: A Risk Factor in Age-Related Maculopathy , 1995, Retina.
[307] R. Pruett,et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy , 1994, Nature Genetics.
[308] Lawrence A. Yannuzzi,et al. Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration , 1994 .
[309] R Hiller,et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. , 1994, JAMA.
[310] D. S. Mcleod,et al. High-resolution histologic analysis of the human choroidal vasculature. , 1994, Investigative ophthalmology & visual science.
[311] A C Bird,et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. , 1994, Ophthalmology.
[312] P T de Jong,et al. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. , 1994, Investigative ophthalmology & visual science.
[313] Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group. , 1993, Archives of ophthalmology.
[314] R. Linsenmeier,et al. Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia , 1992, The Journal of general physiology.
[315] A. Ames,et al. Energy requirements of CNS cells as related to their function and to their vulnerability to ischemia: a commentary based on studies on retina. , 1992, Canadian journal of physiology and pharmacology.
[316] M. Burns,et al. The retinal pigment epithelium induces fenestration of endothelial cells in vivo. , 1992, Current eye research.
[317] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.
[318] W. Sly,et al. Localization of carbonic anhydrase IV in a specific capillary bed of the human eye. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[319] L. Parver,et al. Temperature modulating action of choroidal blood flow , 1991, Eye.
[320] H. Müller-Eberhard,et al. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement. , 1990, Molecular immunology.
[321] A. Bird,et al. Bilaterality of drusen. , 1990, British Journal of Ophthalmology.
[322] A. Hendrickson,et al. Human photoreceptor topography , 1990, The Journal of comparative neurology.
[323] S. Hayreh. In vivo choroidal circulation and its watershed zones , 1990, Eye.
[324] J Seddon,et al. Increased scleral rigidity and age-related macular degeneration. , 1989, Ophthalmology.
[325] M. Killingsworth,et al. Evolution of geographic atrophy of the retinal pigment epithelium , 1988, Eye.
[326] D. Wakefield,et al. HLA ANTIGENS IN OCULAR TISSUES: I. in Vivo Expression in Human Eyes , 1988, Transplantation.
[327] R. Linsenmeier,et al. Effects of light and darkness on oxygen distribution and consumption in the cat retina , 1986, The Journal of general physiology.
[328] M. Elman,et al. Earliest symptoms caused by neovascular membranes in the macula. , 1986, Archives of ophthalmology.
[329] M. Mancini,et al. Does the retinal pigment epithelium polarize the choriocapillaris? , 1986, Investigative ophthalmology & visual science.
[330] P. Penfold,et al. Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. , 1986, Investigative ophthalmology & visual science.
[331] A. Bird,et al. Retinal pigment epithelial detachments in the elderly: classification and outcome. , 1985, The British journal of ophthalmology.
[332] J. Folk. Aging macular degeneration. Clinical features of treatable disease. , 1985, Ophthalmology.
[333] J. Gass,et al. Adult vitelliform macular detachment occurring in patients with basal laminar drusen. , 1985, American journal of ophthalmology.
[334] C. Kilo,et al. Pericyte form and distribution in rat retinal and uveal capillaries. , 1985, Investigative ophthalmology & visual science.
[335] F. Ferris,et al. Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.
[336] M. Hamasaki,et al. Regional difference in fenestration of choroidal capillaries in Japanese monkey eye. , 1982, Japanese journal of ophthalmology.
[337] Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. , 1982, Archives of ophthalmology.
[338] D. Carpenter,et al. Choroidal blood flow as a heat dissipating mechanism in the macula. , 1980, American journal of ophthalmology.
[339] S. Sarks,et al. Ageing and degeneration in the macular region: a clinico-pathological study. , 1976, The British journal of ophthalmology.
[340] S S Hayreh,et al. Segmental nature of the choroidal vasculature. , 1975, The British journal of ophthalmology.
[341] J D Gass,et al. Drusen and disciform macular detachment and degeneration. , 1973, Archives of ophthalmology.
[342] D. Worthen,et al. Histology of the Human Eye. , 1972 .
[343] M. Hogan. Role of the retinal pigment epithelium in macular disease. , 1972, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.
[344] J A Faulkner,et al. Temperature, skeletal muscle mitochondrial functions, and oxygen debt. , 1971, The American journal of physiology.
[345] T KUWABARA,et al. Senile choroidal vascular patterns and drusen. , 1963, Archives of ophthalmology.
[346] Thomas Francis,et al. SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.